Revenue: The sum of all revenue fields included for a company's operating activities.
Provectus Biopharmaceuticals, Inc. (PVCT) had Revenue of $0.62M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.62M |
$-4.73M |
|
-- |
|
$0.62M |
|
$5.15M |
|
$-4.53M |
|
$-0.23M |
|
$-4.76M |
|
$-4.76M |
|
$-4.76M |
|
$-4.76M |
|
$-4.76M |
|
$-4.76M |
|
$-4.53M |
|
$-4.53M |
|
419.81M |
|
419.81M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.98M |
|
$0.00M |
|
$0.03M |
|
$1.01M |
|
$6.98M |
|
-- |
|
-- |
|
$6.98M |
|
$-5.98M |
|
$-5.97M |
|
$-5.97M |
|
420.28M |
|
| Cash Flow Statement Financials | |
$-3.28M |
|
-- |
|
$2.75M |
|
$1.03M |
|
$0.49M |
|
$-0.54M |
|
$1.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
-- |
|
-0.53 |
|
100.00% |
|
-734.42% |
|
-734.42% |
|
-733.26% |
|
-771.65% |
|
-766.85% |
|
$-3.28M |
|
-- |
|
-- |
|
-- |
|
0.61 |
|
-- |
|
-- |
|
-- |
|
79.59% |
|
79.78% |
|
-473.25% |
|
79.78% |
|
$-0.01 |
|
$-0.01 |
|
$-0.01 |
|